logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christopher J. Kane

University of California System
H指数:75
被引数:2.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

COMPARISON OF EMBARK AND EAU CRITERIA TO IDENTIFY HIGH-RISK PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY

比较EMBARK和EAU标准以识别根治性前列腺切除术后生化复发的高风险患者

Journal of Urology
IF6.8
2026-05-010
PRE
Friedrich, Nadine A.; Luu, Michael; Janes, Jessica L.; Kokorowski, Paul; Klaassen, Zachary; Mogollon, Maria P.; Terris, Martha; Kane, Christopher J.; Amling, Christopher; Cooperberg, Matthew; Rivera, Lourdes Guerrios; Aronson, William; Freedland, Stephen J.; Daskivich, Timothy J.
A WEIGHTED SCALE TO IDENTIFY EMBARK-LIKE PATIENTS AT HIGH-RISK FOR PROGRESSION AND MORTALITY AFTER BIOCHEMICAL RECURRENCE (BCR) WHO MAY BENEFIT FROM EARLY INTENSIFIED ADT

一种加权评分系统，用于识别在生化复发（BCR）后可能受益于早期强化雄激素剥夺疗法（ADT）的高风险进展和死亡率的EMBARK样患者

Journal of Urology
IF6.8
2026-05-010
PRE
Friedrich, Nadine A.; Luu, Michael; Janes, Jessica L.; Kokorowski, Paul; Klaassen, Zachary; Mogollon, Maria P.; Terris, Martha; Kane, Christopher J.; Amling, Christopher; Cooperberg, Matthew R.; Rivera, Lourdes Guerrios; Aronson, William; Freedland, Stephen J.; Daskivich, Timothy J.
Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer

患者因素和扫描仪/协议因素对前列腺癌Restriction Spectrum Imaging (RSI)定量MRI生物标志物的系统性影响

Cancer Imaging
IF3.5
2026-04-160
OAAI
Deondre D. Do; Mariluz Rojo Domingo; Christopher C. Conlin; Ian Matthews; Karoline Kallis; Madison T. Baxter; Courtney Ollison; Yuze Song; George Xu; Allison Y. Zhong; Aditya Bagrodia; Tristan Barrett; Matthew Cooperberg; Felix Feng; Michael E. Hahn; Mukesh Harisinghani; Gary M. Hollenberg; Juan Javier-Desloges; Sophia C. Kamran; Christopher J. Kane; Dimitri Kessler; Joshua Kuperman; Kang-Lung Lee; Jonathan Levine; Michael A. Liss; Daniel J. A. Margolis; Paul M. Murphy; Nabih Nakrour; Michael A. Ohliger; Thomas Osinski; Anthony James Pamatmat; Isabella R. Pompa; Rebecca Rakow-Penner; Jacob L. Roberts; Karan Santhosh; Ahmed S. Shabaik; David Song; Clare M. Tempany; Shaun Trecarten; Natasha Wehrli; Eric P. Weinberg; Sean Woolen; Anders M. Dale; Tyler M. Seibert
Alternate definitions of adverse pathology to predict a very high risk of metastasis in men with intermediate- and low-risk prostate cancer

预测中、低风险前列腺癌男性转移风险极高的不良病理的替代定义

CANCER
IF5.1
2025-01-020
PRE
Castaneda, Peris; Kuhlmann, Paige K.; Ithisuphalap, Jaruda; Howard, Lauren E.; Klaassen, Zachary; Rivera, Lourdes Guerrios; Amling, Christopher L.; Aronson, William J.; Cooperberg, Matthew R.; Kane, Christopher J.; Terris, Martha K.; Freedland, Stephen J.
Advanced Restriction Imaging and Reconstruction Technology for Prostate Magnetic Resonance Imaging (ART-Pro): A Study Protocol for a Multicenter, Multinational Trial Evaluating Biparametric Magnetic Resonance Imaging and Advanced, Quantitative Diffusion Magnetic Resonance Imaging for the Detection of Prostate Cancer

前列腺磁共振成像的高级限制性成像和重建技术 (ART-Pro): 一项评估双参数磁共振成像和高级定量扩散磁共振成像检测前列腺癌的多中心，多国试验的研究方案

EUROPEAN UROLOGY OPEN SCIENCE
IF4.5
2025-01-010
OAAI
Baxter, Madison T.; Conlin, Christopher C.; Bagrodia, Aditya; Barrett, Tristan; Bartsch, Hauke; Brau, Anja; Cooperberg, Matthew; Dale, Anders M.; Guidon, Arnaud; Hahn, Michael E.; Harisinghani, Mukesh G.; Javier-DesLoges, Juan F.; Kamran, Sophia C.; Kane, Christopher J.; Kuperman, Joshua M.; Margolis, Daniel J. A.; Murphy, Paul M.; Nakrour, Nabih; Ohliger, Michael A.; Rakow-Penner, Rebecca; Shabaik, Ahmed; Simko, Jeffry P.; Tempany, Clare M.; Wehrli, Natasha; Woolen, Sean A.; Zou, Jingjing; Seibert, Tyler M.
Select black men are potential candidates for prostate hemi-ablation based on radical prostatectomy histopathology for intermediate-risk prostate cancer-a multicenter SEARCH cohort study
PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-08-120
PRE
Deivasigamani, Sriram; Adams, Eric S.; Stock, Shannon; Kotamarti, Srinath; Seguier, Denis; Taha, Tarek; Howard, Lauren E.; Aminsharifi, Alireza; Jibara, Ghalib; Amling, Christopher L.; Aronson, William J.; Cooperberg, Matthew R.; Kane, Christopher J.; Terris, Martha K.; Klaassen, Zachary; Guerrios-Rivera, Lourdes; Freedland, Stephen J.; Polascik, Thomas J.
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort
PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2024-04-110
PRE
Mottaghi, Mahdi; Gu, Lin; Deivasigamani, Sriram; Adams, Eric S.; Parrish, Joshua; Amling, Christopher L.; Aronson, William J.; Kane, Christopher J.; Terris, Martha K.; Guerrios-Rivera, Lourdes; Cooperberg, Matthew R.; Klaassen, Zachary; Freedland, Stephen J.; Polascik, Thomas J.
Blockade of Wnt5A/ROR1 signaling as cancer stem cell targeting therapy for metastatic prostate cancer
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Jamieson, Christina A. M.; Murtadha, Jamillah; Oh, Christopher S.; Muldong, Michelle T.; Etemadfard, Niloofar; Koutouan, Evodie; Yoon, Young E.; Lee, Sanghee; Kwon, Oh; Oh, Jong J.; Kim, Min S.; Willert, Karl; Cacalano, Nicholas A.; Jamieson, Catriona H. M.; Gaasterland, Terry; Mckay, Rana R.; Kane, Christopher J.; Kulidjian, Anna A.; Prussak, Charles E.
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
CANCER
IF5.1
2024-01-014
PRE
Mckay, Rana R.; Xie, Wanling; Yang, Xiaoyu; Acosta, Andres; Rathkopf, Dana; Laudone, Vincent P.; Bubley, Glenn J.; Einstein, David J.; Chang, Peter; Wagner, Andrew A.; Kane, Christopher J.; Preston, Mark A.; Kilbridge, Kerry; Chang, Steven L.; Choudhury, Atish D.; Pomerantz, Mark M.; Trinh, Quoc-Dien; Kibel, Adam S.; Taplin, Mary-Ellen
Pre- clinical studies to advance anti-ROR1 CAR-T cell therapy for metastatic prostate cancer
CANCER RESEARCH
IF16.6
2023-04-040
PRE
Jamieson, Christina A. M.; Murtadha, Jamillah; Oh, Christopher S.; Muldong, Michelle; Koutouan, Evodie; Kim, JOngwook; Etemadfard, Niloofar; Choo, Hae Soo; Sinha, Navyaa; Lee, Sanghee; Wu, Christina; Pineda, Gabriel; Lennon, Kathleen; Willert, Karl; Jamieson, Catriona H.; Gaasterland, Terry; Mckay, Rana; Kane, Christopher J.; Kipps, Thomas J.; Kulidjian, Anna A.; Cacalano, Nicholas A.; Prussak, Charles
Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)?
PROSTATE CANCER AND PROSTATIC DISEASES
IF5.8
2022-09-012
PRE
Klaassen, Zachary; Howard, Lauren; Wallis, Christopher J. D.; Janes, Jessica L.; De Hoedt, Amanda; Aronson, William J.; Polascik, Thomas J.; Amling, Christopher J.; Kane, Christopher J.; Cooperberg, Matthew R.; Terris, Martha K.; Wu, Yuan; Freedland, Stephen J.
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management

临床局限性前列腺癌: AUA/ASTRO指南，第一部分: 介绍，风险评估，分期和基于风险的管理

JOURNAL OF UROLOGY
IF6.8
2022-07-01202
PRE
Eastham, James A.; Auffenberg, Gregory B.; Barocas, Daniel A.; Chou, Roger; Crispino, Tony; Davis, John W.; Eggener, Scott; Horwitz, Eric M.; Kane, Christopher J.; Kirkby, Erin; Lin, Daniel W.; McBride, Sean M.; Morgans, Alicia K.; Pierorazio, Phillip M.; Rodrigues, George; Wong, William W.; Boorjian, Stephen A.

研究方向

暂未获取到该数据
S
Stephen J. Freedland
H 指数:98论文数:1,642被引数:4.3万
W
William J. Aronson
H 指数:70论文数:564被引数:1.8万
M
Martha K. Terris
H 指数:63论文数:745被引数:1.6万
C
Christopher L. Amling
H 指数:61论文数:506被引数:1.4万
J
Joseph C. Presti
H 指数:65论文数:375被引数:1.3万
M
Matthew R. Cooperberg
H 指数:86论文数:1,091被引数:3.3万
L
Lauren E. Howard
H 指数:34论文数:470被引数:4,200
P
Peter R. Carroll
H 指数:149论文数:1,425被引数:10.6万
D
Daniel M. Moreira
H 指数:43论文数:357被引数:5,781
L
Lionel L. Bañez
H 指数:31论文数:273被引数:3,330